DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Enanta Pharmaceuticals, Inc. (ENTA)
« Back to company indexENTA Chatter Timeline
Stock Ticker for ENTA
Most Active Tweeters for ENTA
| User | Tweets |
|---|---|
| @bulletin_en | 10 |
| @AmericanBanking | 6 |
| @dakotafinancial | 2 |
| @dailypoliticaln | 2 |
| @DataTrials | 2 |
Recent Tweets for ENTA
 |
@jcmccune3 RT @MarketWebs: @jcmccune3 asked about $ENTA. There's a great breakout happening on the 1hr towards two VPOCS up to 98.6. The 80% rule on… May 22nd 2019, 9:05pm |
 |
@MarketWebs @jcmccune3 asked about $ENTA. There's a great breakout happening on the 1hr towards two VPOCS up to 98.6. The 80%… https://t.co/4cnegfldwU May 22nd 2019, 9:05pm |
 |
@bulletin_en Anchiano Therapeutics Ltd $ENTA Comparison side by side https://t.co/FHNroq18Ky May 21st 2019, 6:05pm |
|
@bulletin_en Enanta Pharmaceuticals $ENTA Share Value Rose While Algert Global Upped Its Holding; As United Bankshares $UBSI Sto… https://t.co/FXOWSKybFG May 21st 2019, 8:05am |
 |
@WKRBNews Enanta Pharmaceuticals Inc $ENTA Expected to Announce Earnings of -$0.04 Per Share https://t.co/lLxwOMi6hn #markets May 19th 2019, 6:05pm |
|
@bulletin_en Reviewing Tiziana Life Sciences PLC $ENTA's results https://t.co/CGvUstA09c May 19th 2019, 9:05am |
|
@bulletin_en Comparing of Galmed Pharmaceuticals Ltd. $ENTA https://t.co/K1fc499zOT May 18th 2019, 9:05pm |
|
@bulletin_en Reviewing ERYTECH Pharma S.A. $ENTA's results https://t.co/rycwaB71fq May 18th 2019, 9:05pm |
|
@bulletin_en Cytokinetics Incorporated $ENTA https://t.co/qH0u0DHQBQ May 18th 2019, 4:05pm |
 |
@AmericanBanking Head to Head Contrast: Enanta Pharmaceuticals $ENTA versus Albireo Pharma $ALBO https://t.co/B5RrSmf6NY #stocks May 17th 2019, 2:05pm |
|
@bulletin_en As Enanta Pharmaceuticals $ENTA Share Value Rose, Krensavage Asset Management Has Upped by $1.65 Million Its Holdin… https://t.co/ze2iNqech1 May 17th 2019, 11:05am |
|
@AmericanBanking Enanta Pharmaceuticals Inc $ENTA Given Consensus Recommendation of “Buy” by Analysts https://t.co/KdUqPOzRvU #stocks May 17th 2019, 10:05am |
 |
@TickerReport Enanta Pharmaceuticals Inc $ENTA Expected to Post Earnings of -$0.04 Per Share https://t.co/nnIUSTAtd7 May 17th 2019, 5:05am |
 |
@registrarjourn $47.28 Million in Sales Expected for Enanta Pharmaceuticals Inc $ENTA This Quarter https://t.co/klHENysai6 May 16th 2019, 1:05am |
 |
@EnterpriseLeade $47.28 Million in Sales Expected for Enanta Pharmaceuticals Inc $ENTA This Quarter https://t.co/IFy5o4WQpL May 16th 2019, 1:05am |
|
@AmericanBanking $47.28 Million in Sales Expected for Enanta Pharmaceuticals Inc $ENTA This Quarter https://t.co/eccWe16xo0 #stocks May 16th 2019, 1:05am |
 |
@dakotafinancial Brokers Offer Predictions for Enanta Pharmaceuticals Inc’s Q3 2019 Earnings $ENTA https://t.co/iOijsqWhNC May 15th 2019, 3:05am |
|
@AmericanBanking Zacks: Analysts Expect Enanta Pharmaceuticals Inc $ENTA to Post -$0.04 EPS https://t.co/aUi4zE18Yd #stocks May 14th 2019, 8:05pm |
 |
@DataTrials $ENTA Phase 2 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With… https://t.co/k08KejefWz May 14th 2019, 5:05pm |
|
@DataTrials $ENTA Phase 2 A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model… Estimated Primary Completion Date - 06/2019 May 14th 2019, 5:05pm |
 |
@stocknewstimes Enanta Pharmaceuticals $ENTA Rating Increased to Buy at Zacks Investment Research https://t.co/xH7oVYnqr1 May 14th 2019, 6:05am |
 |
@SleekMoneycom Enanta Pharmaceuticals $ENTA Rating Increased to Buy at Zacks Investment Research https://t.co/alQs7UJvdC #investing May 14th 2019, 6:05am |
 |
@macondailynews Enanta Pharmaceuticals $ENTA Rating Increased to Buy at Zacks Investment Research https://t.co/BHYW858Abb May 14th 2019, 6:05am |
 |
@WatchlistN Enanta Pharmaceuticals Inc Forecasted to Earn Q3 2019 Earnings of -$0.04 Per Share $ENTA https://t.co/kofuXa0EEp May 14th 2019, 2:05am |
|
@bulletin_en Corcept Therapeutics Incorporated $ENTA Comparison side by side https://t.co/CpScjb178w May 14th 2019, 2:05am |
|
@dakotafinancial Enanta Pharmaceuticals $ENTA Stock Rating Upgraded by BidaskClub https://t.co/dHIFGrhnA8 May 13th 2019, 10:05am |
 |
@dispatchtribune Enanta Pharmaceuticals $ENTA Raised to Buy at Zacks Investment Research https://t.co/6KRZjZBoms May 13th 2019, 8:05am |
 |
@dailypoliticaln Enanta Pharmaceuticals Inc $ENTA to Post Q3 2019 Earnings of -$0.04 Per Share, Oppenheimer Forecasts https://t.co/DHAfil29Gz May 13th 2019, 3:05am |
|
@AmericanBanking Enanta Pharmaceuticals Inc $ENTA to Post Q3 2019 Earnings of -$0.04 Per Share, Oppenheimer Forecasts https://t.co/hgBLcy0kIJ #stocks May 13th 2019, 3:05am |
 |
@TranscriptDaily Enanta Pharmaceuticals $ENTA Raised to Buy at Zacks Investment Research https://t.co/luiEGZrxMO May 12th 2019, 8:05am |
|
@bulletin_en Great Point Partners Stake in Enanta Pharmaceuticals $ENTA Trimmed by $4.68 Million; Investmentaktiengesellschaft F… https://t.co/gCiJzLpcns May 12th 2019, 8:05am |
 |
@bbnsnews Enanta Pharmaceuticals $ENTA Upgraded at Zacks Investment Research https://t.co/uevdTxIk2g May 11th 2019, 4:05pm |
|
@dailypoliticaln Enanta Pharmaceuticals $ENTA Upgraded to Strong-Buy at BidaskClub https://t.co/n6ILQiJr2O May 11th 2019, 1:05am |
 |
@TheMarketsDaily Enanta Pharmaceuticals $ENTA Upgraded to Buy at Zacks Investment Research https://t.co/Qtg3nltBjI May 10th 2019, 10:05pm |
|
@bulletin_en Reviewing Arbutus Biopharma Corporation $ENTA's results https://t.co/uZwtWVSZN6 May 10th 2019, 10:05pm |
 |
@WeekHerald Enanta Pharmaceuticals $ENTA Lifted to Strong-Buy at BidaskClub https://t.co/9FR9HT3GYp May 10th 2019, 5:05pm |
 |
@Stock_News_Now $ENTA: New SEC Filing for ENTA: Form 10-Q (No. 0001564590-19-018517): https://t.co/M3ijd0xN6C May 10th 2019, 4:05pm |
 |
@ThisLincolnian Oppenheimer Comments on Enanta Pharmaceuticals Inc’s FY2019 Earnings $ENTA https://t.co/tp5pk9Qx87 May 10th 2019, 8:05am |
|
@AmericanBanking Oppenheimer Comments on Enanta Pharmaceuticals Inc’s FY2019 Earnings $ENTA https://t.co/83HF6yoxqX #stocks May 10th 2019, 8:05am |
 |
@FinZTribune RedHill Biopharma Ltd. $ENTA Comparison side by side https://t.co/LTJubIrTMQ May 9th 2019, 6:05pm |
 |
@DewDiligence $ENTA new corp slide set: https://t.co/DDdChWOG02 May 9th 2019, 3:05pm |
|
@TranscriptDaily Enanta Pharmaceuticals $ENTA Releases Earnings Results, Beats Estimates By $0.29 EPS https://t.co/ZzzkP9uqj7 May 9th 2019, 1:05pm |
|
@ThisLincolnian Enanta Pharmaceuticals $ENTA Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS https://t.co/ZRdVAi9Cyl May 9th 2019, 12:05am |
|
@AmericanBanking Enanta Pharmaceuticals $ENTA Releases Earnings Results, Beats Expectations By $0.29 EPS https://t.co/wpoNi5zQ8y #stocks May 8th 2019, 11:05pm |
 |
@semodough $ENTA phase 2a EDP-938 for RSV healthy challenge data mid-year phase 2 EDP-305 for NASH data in 3Q (ARGON-1). Pendi… https://t.co/59YmTWejXn May 8th 2019, 3:05pm |
|
@FinZTribune As Enanta Pharmaceuticals $ENTA Stock Value Rose, Krensavage Asset Management Has Increased Stake; Martin Currie LT… https://t.co/O5pPymYykJ May 8th 2019, 5:05am |
 |
@SiteFocusHQ $ENTA Qualitative Analysis of recent earnings identified Enanta Pharmaceuticals (ENTA) business focus on (edp-,rsv)… https://t.co/ouvlUUQuhv May 7th 2019, 10:05pm |
 |
@SeekingAlpha $ENTA - Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q2 2019 Results - Earnings Call Transcript https://t.co/DLrxMh5Ka5 May 7th 2019, 9:05pm |
 |
@ProVesting $ENTA: Enanta Pharmaceuticals, Inc. (ENTA) Q2 2019 Earnings Call …: https://t.co/cxdMZ8LtNn May 7th 2019, 9:05pm |
 |
@Briefingcom $ENTA: Enanta Pharmaceuticals beats by $0.25, misses on revs https://t.co/Fh8cCbDql7 May 7th 2019, 6:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.